Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
2023 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Anker, S. D.; Usman, M. S.; Anker, M. S.; Butler, J.; Böhm, M.; Abraham, W. T. & Adamo, M. et al. (2023)
European Journal of Heart Failure, 25(7) pp. 936-955. DOI: https://doi.org/10.1002/ejhf.2894
Documents & Media
Details
- Authors
- Anker, Stefan D.; Usman, Muhammad Shariq; Anker, Markus S.; Butler, Javed; Böhm, Michael; Abraham, William T.; Adamo, Marianna; Chopra, Vijay K.; Cicoira, Mariantonietta; Cosentino, Francesco; Rosano, Giuseppe M.C.
- Abstract
- Abstract Heart failure with preserved ejection fraction (HFpEF) represents a highly heterogeneous clinical syndrome affected in its development and progression by many comorbidities. The left ventricular diastolic dysfunction may be a manifestation of various combinations of cardiovascular, metabolic, pulmonary, renal, and geriatric conditions. Thus, in addition to treatment with sodium–glucose cotransporter 2 inhibitors in all patients, the most effective method of improving clinical outcomes may be therapy tailored to each patient's clinical profile. To better outline a phenotype‐based approach for the treatment of HFpEF, in this joint position paper, the Heart Failure Association of the European Society of Cardiology, the European Heart Rhythm Association and the European Hypertension Society, have developed an algorithm to identify the most common HFpEF phenotypes and identify the evidence‐based treatment strategy for each, while taking into account the complexities of multiple comorbidities and polypharmacy.
- Issue Date
- 2023
- Journal
- European Journal of Heart Failure
- ISSN
- 1388-9842
- eISSN
- 1879-0844
- Language
- English